Uganda trials Ebola vaccine as countries rush to tame spread
A Ugandan contact of a patient who tested positive for Ebola is vaccinated with a trial vaccine at the Mulago Guest House (isolation centre) in Kampala on February 3, 2025.
Ugandan scientists have begun the first phase of human clinical trials for an experimental vaccine targeting the Bundibugyo strain of Ebola, offering hope of a longer-term defence against a viral disease that has so far spread across three regions of Africa.
